|
1
|
Harnessing Artificial Intelligence and 3D Tissue Engineering for Precision Drug Screening in Giant Cell Tumor of Bone: Next-Gen Tumor Therapeutics
|
ICMR
|
2025-2026
|
Dr.Amitkumar Jaiswal
|
Dr. Ramanathan K SBST
|
59,99,000/-
|
|
2
|
Unveiling and reprogramming the cellular package mechanism of tumour extracellular vesicles to combat cancer metastasis
|
ANRF
|
2025-2026
|
Dr. Arunkumar Pitchaimani
|
|
57,50,000/-
|
|
3
|
Bioengineered Theranostic Integrated Medical Implant Surfaces for Real-Time Sensing and Combat of Antimicrobial Resistant Infections
|
ICMR
|
2025-2026
|
Dr. Anjaneyulu U
|
|
2,08,00,000/- (VIT 1,22,00,000/-)
|
|
4
|
Metabolomic Signature of Renal Tubular-Specific Extracellular Vesicles in Diabetic Kidney Disease: A Predictive Biomarker Study with Machine Learning Integration
|
ICMR
|
2025-2026
|
Dr. Ramprasad Srinivasan SNHRC
|
Dr. Arunkumar Pitchaimani
|
1,20,00,00/- (VIT 23,00,000)
|
|
5
|
Placental-Derived Biomaterials for Advancing Implant Acceptance and Tissue Regeneration
|
MHRD
|
2025-2026
|
|
Dr.Amitkumar Jaiswal
|
47,97,000/-
|
|
6
|
Small Molecule/Peptide Conjugated Receptor Targeted In Vivo miRNA Delivery System for Restoring Infracted Myocardium
|
ICMR
|
2025-2026
|
Dr.Loganathan Rangasamy
|
Dr. Arunkumar Pitchaimani, Dr.Joseph Nathanael A
|
1,30,00,000/-
|
|
7
|
Fabrication of sheet nanoemulgel for treating open surface wounds particularly for subjects presenting delayed wound healing and pressure sores
|
DBT
|
2024-25
|
Dr.Priyanaka Srivatsav
|
Dr.Raunak Kumar Das
|
10,48,870/-
|
|
8
|
Personalized Mitochondria as a Therapeutic Vehicle: An Organelle Mediated Gene Delivery Platform for the Treatment of Alzheimer Disease.
|
ICMR
|
2024-25
|
Dr. Arunkumar Pitchaimani
|
Dr.Raunak Kumar Das
|
1,33,48,901/-
|
|
9
|
Click Chemistry Induced Cell-Laden 3D Hydrogel Integrated Orthopaedic Implants to Combat Infections and Osteointegration Failure
|
Start-up Research Grant (SRG)Science and Engineering ResearchBoard(SERB)
|
2024-25
|
Dr. Anjaneyulu U
|
|
30,23,372/-
|
|
10
|
Technology development for cardiovascular disease diagnosis and management
|
IAMRAI
|
2024-25
|
Dr. Geetha Manivasagam
|
Dr.Arunkumar Palaniappan, Dr.Kishor Lakshmi Narayanan
|
46,80,000/-
|
|
11
|
Functionalised Graphene Quantum Dots Iron Oxide Formulation for the Therapeutic Assessment of 3D Triple-Negative Breast Cancer Model in Hyperthermia Condition
|
ICMR
|
2023-24
|
Dr.Niroj Kumar Sahu
|
Dr.Arunkumar Palaniappan
|
33,14,085/-
|
|
12
|
Design and Development of Siderophore-Macrolide Antibiotic Conjugates to Combat Multidrug Resistance (MDR) Gram-Negative Bacterial Infections
|
ICMR
|
2023-24
|
Dr.Loganathan Rangasamy
|
Dr. Geetha Manivasagam, Dr. Anjaneyulu U, Dr.Ramesh N
|
52,68,585/-
|
|
13
|
3D printed nano-engineered sublingual patch with viral-mimetic nanoparticles for non-invasive delivery of Insulin
|
ICMR
|
2023-24
|
Dr.Arunkumar Palaniappan
|
Dr.Sankar Ganesh D
|
46,69,785/-
|
|
14
|
Injectable dental biomaterial with osteogenic and antimicrobial properties- an attempt towards indigenization of multifunctional dental biomaterial
|
ICMR
|
2023-24
|
Dr.Amitkumar Jaiswal
|
Dr.Arunkumar Palaniappan, Dr.Raunak Kumar Das
|
39,51,000/-
|
|
15
|
Development of super hemophobic surfaces
|
DST-SPARC
|
2023-24
|
Dr.Renold Elsen S
|
Dr. Geetha Manivasagam, Dr.Sunita Nayak
|
50,22,900/-
|
|
16
|
Development of Concentration Gradient Microfluidic Needle Patch for Combinatorial Diabetic Therapy
|
DBT
|
2023-24
|
Dr. Arunkumar Pitchaimani
|
Dr.Sushma kumari
|
22,92,498/-
|
|
17
|
Development of Self-feeding hydrogel based Bio-Ink formulation for 3D bioprinting
|
DST-SERB
|
2023-24
|
Dr.Amitkumar Jaiswal
|
|
17,05,881/-
|
|
18
|
Assessment of permeation and toxicity of nanoparticles on polysaccharide-based 3D bioprinted bilayered skin substitute
|
DSTINAU
|
2022-23
|
Dr.Amitkumar Jaiswal
|
|
6,60,000/-
|
|
19
|
Biomaterial -based Biomimetic Scaffolds for Tissue Engineering Applications
|
DST
|
2022-23
|
Dr.Sushma kumari
|
|
35,00,000/-
|
|
20
|
Regulation of epithelial-mesenchymal transition in oral squamous cell carcinoma with an in-vitro model using 3D printed polycaprolactone-collagen scaffold
|
ICMR
|
2022-23
|
Dr.Amitkumar Jaiswal
|
|
29,49,000/-
|
|
21
|
Radiolabeled Fibroblast Activation Protein Inhibitors as Novel Radipharmaceuticals Targeting CAFs
|
BRNS
|
2022-23
|
Dr.Loganathan Rangasamy
|
|
37,19,300/-
|
